US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rite Aid

0.6483

0.0000

Volume:- -

Turnover:1.70M

Market Cap:35.78M

PE:-0.04

High:0.6483

Open:0.6483

Low:0.6483

Close:0.6483

52wk High:7.37

52wk Low:0.3779

Shares:55.19M

Float Shares:54.03M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-17.2436

EPS(LYR):-13.7150

ROE:-2628.85%

ROA:0.08%

PB:-0.04

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

Radiopharm Theranostics Gains Approval for Phase 1 Trial of RAD 402 in Prostate Cancer

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases

Artificial Intelligence Technology Solutions Secures Major RAD Order

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204

T RAD Co Raises FY Net View to Y6.40B

Artificial Intelligence Technology Solutions Secures Major RAD Contract

C-RAD AB Announces Share Repurchase Program to Optimize Capital Structure

C-RAD AB Reports Strong Q3 2025 Earnings and Strategic Growth Initiatives

C-RAD Announces Leadership Transition with New Acting CEO

C-RAD Expedites Q3 2025 Interim Report Approval

Press Release: Hilco Global Seeks Offers to Acquire Consumer IP Assets of Rite Aid(R)

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CVS Pharmacy completes acquisition of Rite Aid assets nationwide

C-RAD to Present Q3 2025 Interim Report

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial

C-RAD Expands Czech Market Presence with Key Hospital Order

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RAD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAD\",,,,,undefined,":{"symbol":"RAD","market":"US","secType":"STK","nameCN":"Rite Aid","latestPrice":0.6483,"timestamp":1697227200000,"preClose":0.6483,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":54031602,"shares":55186332,"eps":-17.24361,"marketStatus":"Delisted","change":0,"latestTime":"10-13 16:00:00 EDT","open":0.6483,"high":0.6483,"low":0.6483,"amount":1700754.6221534,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-17.24361,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":0.6483,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAD\",,,,,undefined,":{"symbol":"RAD","floatShares":54031602,"roa":"0.08%","roe":"-2628.85%","lyrEps":-13.714996,"shares":55186332,"dividePrice":0,"high":0.6483,"amplitude":0,"preClose":0.6483,"low":0.6483,"week52Low":0.3779,"pbRate":"-0.04","psRate":"0.00","week52High":7.37,"institutionHeld":0.3536,"latestPrice":0.6483,"eps":-17.24361,"divideRate":0,"volume":0,"delay":0,"ttmEps":-17.24361,"open":0.6483},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-06-29","symbol":"RAD","fiscalQuarterEnding":"2023/05","expectedEps":-1.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1688011200000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2023-04-20","symbol":"RAD","fiscalQuarterEnding":"2023/02","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1681963200000,"reportTimeType":"pre","actualEps":-1.24},{"market":"US","date":"2022-12-21","symbol":"RAD","fiscalQuarterEnding":"2022/11","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1671598800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2022-09-29","symbol":"RAD","fiscalQuarterEnding":"2022/08","expectedEps":-0.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1664424000000,"reportTimeType":"pre","actualEps":-0.63},{"market":"US","date":"2022-06-23","symbol":"RAD","fiscalQuarterEnding":"2022/05","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1655956800000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1649390400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAD","date":"2023-10-13","current":-0.037597,"percent":0.878497,"low":-25.038468,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"high":1.97654,"avg":-2.636866,"sd":4.987595,"marketCap":43006708},"quantilePoints":[{"date":"2021-04-01","current":-2.911852,"twenty":-1.577354,"median":1.512548,"eighty":10.532334,"marketCap":1156398161},{"date":"2021-04-09","current":-2.795044,"twenty":-1.595488,"median":1.488668,"eighty":4.690071,"marketCap":1110009696},{"date":"2021-04-16","current":-10.715746,"twenty":-1.611063,"median":1.471557,"eighty":4.623178,"marketCap":974157763},{"date":"2021-04-23","current":-11.159198,"twenty":-1.6234,"median":1.452906,"eighty":4.461534,"marketCap":1014471548},{"date":"2021-04-30","current":-10.370016,"twenty":-1.647845,"median":1.436031,"eighty":4.417812,"marketCap":942727740},{"date":"2021-05-07","current":-10.660044,"twenty":-1.65381,"median":1.411668,"eighty":4.362436,"marketCap":969093984},{"date":"2021-05-14","current":-11.322968,"twenty":-1.661953,"median":1.385831,"eighty":4.327646,"marketCap":1029359684},{"date":"2021-05-21","current":-11.299729,"twenty":-1.673097,"median":1.376704,"eighty":4.254903,"marketCap":1027247064},{"date":"2021-05-28","current":-10.814356,"twenty":-1.688933,"median":1.361536,"eighty":4.172673,"marketCap":983122256},{"date":"2021-06-04","current":-12.347425,"twenty":-1.694503,"median":1.352943,"eighty":4.100383,"marketCap":1122492078},{"date":"2021-06-11","current":-13.193869,"twenty":-1.705954,"median":1.330485,"eighty":4.061989,"marketCap":1199441439},{"date":"2021-06-18","current":-11.921244,"twenty":-1.726912,"median":1.313217,"eighty":4.039978,"marketCap":1083748343},{"date":"2021-06-25","current":-21.843767,"twenty":-1.751365,"median":1.278807,"eighty":4.021969,"marketCap":883034276},{"date":"2021-07-02","current":-21.085025,"twenty":-1.756945,"median":1.263875,"eighty":3.974476,"marketCap":852362153},{"date":"2021-07-09","current":-19.64741,"twenty":-1.766291,"median":1.25339,"eighty":3.974476,"marketCap":794246551},{"date":"2021-07-16","current":-18.183172,"twenty":-1.788979,"median":1.232001,"eighty":3.974476,"marketCap":735054735},{"date":"2021-07-23","current":-19.447741,"twenty":-1.813323,"median":1.208559,"eighty":3.974476,"marketCap":786174940},{"date":"2021-07-30","current":-20.233105,"twenty":-1.839645,"median":1.199583,"eighty":3.974476,"marketCap":817923278},{"date":"2021-08-06","current":-19.208139,"twenty":-1.883371,"median":1.193006,"eighty":3.974476,"marketCap":776489007},{"date":"2021-08-13","current":-20.219794,"twenty":-1.90008,"median":1.169641,"eighty":3.974476,"marketCap":817385170},{"date":"2021-08-20","current":-21.35125,"twenty":-1.918567,"median":1.155123,"eighty":3.974476,"marketCap":863124301},{"date":"2021-08-27","current":-22.695687,"twenty":-1.94117,"median":1.13789,"eighty":3.974476,"marketCap":917473151},{"date":"2021-09-03","current":-24.519329,"twenty":-1.945476,"median":1.126691,"eighty":3.974476,"marketCap":991193867},{"date":"2021-09-10","current":-23.614164,"twenty":-1.957425,"median":1.111528,"eighty":3.897517,"marketCap":954602563},{"date":"2021-09-17","current":-23.161581,"twenty":-1.977444,"median":1.096234,"eighty":3.844883,"marketCap":936306910},{"date":"2021-09-24","current":-6.202651,"twenty":-2.004891,"median":1.06089,"eighty":3.777564,"marketCap":791017907},{"date":"2021-10-01","current":-5.907287,"twenty":-2.015988,"median":0.97941,"eighty":3.722279,"marketCap":753350388},{"date":"2021-10-08","current":-5.796726,"twenty":-2.027502,"median":-0.378346,"eighty":3.710917,"marketCap":739250667},{"date":"2021-10-15","current":-5.885972,"twenty":-2.052681,"median":-0.408292,"eighty":3.632639,"marketCap":750632092},{"date":"2021-10-22","current":-6.055964,"twenty":-2.081182,"median":-0.42217,"eighty":3.5201,"marketCap":772310997},{"date":"2021-10-29","current":-5.775477,"twenty":-2.128132,"median":-0.475489,"eighty":3.412568,"marketCap":736540804},{"date":"2021-11-05","current":-6.162209,"twenty":-2.164758,"median":-0.491558,"eighty":3.217344,"marketCap":785860313},{"date":"2021-11-12","current":-5.856223,"twenty":-2.199907,"median":-0.503244,"eighty":3.175266,"marketCap":746838284},{"date":"2021-11-19","current":-5.456742,"twenty":-2.223123,"median":-0.512739,"eighty":3.079242,"marketCap":695892856},{"date":"2021-11-26","current":-5.261251,"twenty":-2.281044,"median":-0.519313,"eighty":2.955052,"marketCap":670962115},{"date":"2021-12-03","current":-5.099759,"twenty":-2.316548,"median":-0.540494,"eighty":2.842958,"marketCap":650367156},{"date":"2021-12-10","current":-5.460992,"twenty":-2.353892,"median":-0.56898,"eighty":2.686476,"marketCap":696434829},{"date":"2021-12-17","current":-5.121008,"twenty":-2.4532,"median":-0.600387,"eighty":2.568306,"marketCap":653077019},{"date":"2021-12-23","current":-4.505922,"twenty":-2.508599,"median":-0.626681,"eighty":2.507595,"marketCap":756593791},{"date":"2021-12-31","current":-4.741546,"twenty":-2.57925,"median":-0.66101,"eighty":2.477239,"marketCap":796157793},{"date":"2022-01-07","current":-4.20589,"twenty":-2.629288,"median":-0.690956,"eighty":2.456641,"marketCap":706215237},{"date":"2022-01-14","current":-3.99608,"twenty":-2.711053,"median":-0.823004,"eighty":2.399182,"marketCap":670985774},{"date":"2022-01-21","current":-3.408611,"twenty":-2.724403,"median":-0.858764,"eighty":2.299442,"marketCap":572343277},{"date":"2022-01-28","current":-3.363421,"twenty":-2.754223,"median":-0.886037,"eighty":2.227889,"marketCap":564755393},{"date":"2022-02-04","current":-3.366649,"twenty":-2.819329,"median":-0.905303,"eighty":2.203849,"marketCap":565297384},{"date":"2022-02-11","current":-3.30532,"twenty":-2.898502,"median":-0.924759,"eighty":2.183095,"marketCap":554999541},{"date":"2022-02-18","current":-3.218168,"twenty":-2.97031,"median":-0.953199,"eighty":2.153084,"marketCap":540365764},{"date":"2022-02-25","current":-3.001902,"twenty":-2.979684,"median":-0.960268,"eighty":2.141159,"marketCap":504052318},{"date":"2022-03-04","current":-2.963167,"twenty":-2.98318,"median":-0.977626,"eighty":2.035998,"marketCap":497548417},{"date":"2022-03-11","current":-2.937345,"twenty":-3.004194,"median":-0.992727,"eighty":1.99157,"marketCap":493212483},{"date":"2022-03-18","current":-3.014813,"twenty":-3.013653,"median":-1.009165,"eighty":1.980454,"marketCap":506220285},{"date":"2022-03-25","current":-3.147155,"twenty":-3.04173,"median":-1.034981,"eighty":1.947561,"marketCap":528441946},{"date":"2022-04-01","current":-2.685572,"twenty":-3.048412,"median":-1.04628,"eighty":1.923829,"marketCap":450937127},{"date":"2022-04-08","current":-2.424116,"twenty":-3.048412,"median":-1.068153,"eighty":1.903372,"marketCap":407035796},{"date":"2022-04-14","current":-0.726711,"twenty":-3.048412,"median":-1.082216,"eighty":1.890234,"marketCap":391318036},{"date":"2022-04-22","current":-0.746842,"twenty":-3.048412,"median":-1.082216,"eighty":1.876222,"marketCap":402157871},{"date":"2022-04-29","current":-0.640144,"twenty":-3.048412,"median":-1.082216,"eighty":1.867738,"marketCap":344703689},{"date":"2022-05-06","current":-0.649189,"twenty":-3.048412,"median":-1.082216,"eighty":1.856593,"marketCap":349573914},{"date":"2022-05-13","current":-0.573819,"twenty":-3.048412,"median":-1.082216,"eighty":1.847061,"marketCap":308988707},{"date":"2022-05-20","current":-0.564774,"twenty":-3.048412,"median":-1.082216,"eighty":1.835935,"marketCap":304118482},{"date":"2022-05-27","current":-0.577838,"twenty":-3.048412,"median":-1.082216,"eighty":1.825414,"marketCap":311153251},{"date":"2022-06-03","current":-0.612006,"twenty":-3.048412,"median":-1.082216,"eighty":1.82031,"marketCap":329551878},{"date":"2022-06-10","current":-0.622031,"twenty":-3.048412,"median":-1.082216,"eighty":1.811817,"marketCap":334949807},{"date":"2022-06-17","current":-0.623036,"twenty":-3.048412,"median":-1.082216,"eighty":1.811817,"marketCap":335490921},{"date":"2022-06-24","current":-0.739804,"twenty":-3.049731,"median":-1.083984,"eighty":1.805154,"marketCap":470228404},{"date":"2022-07-01","current":-0.58316,"twenty":-3.049731,"median":-1.083984,"eighty":1.798366,"marketCap":370663357},{"date":"2022-07-08","current":-0.604874,"twenty":-3.049731,"median":-1.083984,"eighty":1.792416,"marketCap":384465115},{"date":"2022-07-15","current":-0.573219,"twenty":-3.049731,"median":-1.083984,"eighty":1.771425,"marketCap":364344593},{"date":"2022-07-22","current":-0.62284,"twenty":-3.049731,"median":-1.083984,"eighty":1.721985,"marketCap":395884871},{"date":"2022-07-29","current":-0.704118,"twenty":-3.049731,"median":-1.083984,"eighty":1.699206,"marketCap":447545671},{"date":"2022-08-05","current":-0.76914,"twenty":-3.049731,"median":-1.083984,"eighty":1.66801,"marketCap":488874312},{"date":"2022-08-12","current":-0.945383,"twenty":-3.049731,"median":-1.083984,"eighty":1.655123,"marketCap":600896679},{"date":"2022-08-19","current":-0.658774,"twenty":-3.049731,"median":-1.083984,"eighty":1.646527,"marketCap":418724383},{"date":"2022-08-26","current":-0.701551,"twenty":-3.049731,"median":-1.083984,"eighty":1.617069,"marketCap":445914278},{"date":"2022-09-02","current":-0.586052,"twenty":-3.049731,"median":-1.083984,"eighty":1.597109,"marketCap":372501561},{"date":"2022-09-09","current":-0.652785,"twenty":-3.049731,"median":-1.083984,"eighty":1.579423,"marketCap":414917797},{"date":"2022-09-16","current":-0.654496,"twenty":-3.049731,"median":-1.083984,"eighty":1.5683,"marketCap":416005393},{"date":"2022-09-23","current":-0.599741,"twenty":-3.049731,"median":-1.083984,"eighty":1.557113,"marketCap":381202327},{"date":"2022-09-30","current":-0.310616,"twenty":-3.049731,"median":-1.083984,"eighty":1.522155,"marketCap":269179960},{"date":"2022-10-07","current":-0.293008,"twenty":-3.049731,"median":-1.083984,"eighty":1.508408,"marketCap":253921443},{"date":"2022-10-14","current":-0.243753,"twenty":-3.049731,"median":-1.083984,"eighty":1.482287,"marketCap":211236373},{"date":"2022-10-21","current":-0.265223,"twenty":-3.049731,"median":-1.083984,"eighty":1.454446,"marketCap":229842685},{"date":"2022-10-28","current":-0.309427,"twenty":-3.049731,"median":-1.083984,"eighty":1.437335,"marketCap":268149800},{"date":"2022-11-04","current":-0.341001,"twenty":-3.049731,"median":-1.083984,"eighty":1.41509,"marketCap":295512024},{"date":"2022-11-11","current":-0.380153,"twenty":-3.049731,"median":-1.083984,"eighty":1.38698,"marketCap":329441182},{"date":"2022-11-18","current":-0.355525,"twenty":-3.049731,"median":-1.083984,"eighty":1.379596,"marketCap":308098647},{"date":"2022-11-25","current":-0.342896,"twenty":-3.049731,"median":-1.083984,"eighty":1.367771,"marketCap":297153758},{"date":"2022-12-02","current":-0.322688,"twenty":-3.049731,"median":-1.083984,"eighty":1.354775,"marketCap":279641934},{"date":"2022-12-09","current":-0.280379,"twenty":-3.049731,"median":-1.083984,"eighty":1.330418,"marketCap":242976553},{"date":"2022-12-16","current":-0.269644,"twenty":-3.049731,"median":-1.083984,"eighty":1.312348,"marketCap":233673397},{"date":"2022-12-23","current":-0.209708,"twenty":-3.049731,"median":-1.083984,"eighty":1.278807,"marketCap":188252104},{"date":"2022-12-30","current":-0.203612,"twenty":-3.049731,"median":-1.083984,"eighty":1.268124,"marketCap":182779659},{"date":"2023-01-06","current":-0.210605,"twenty":-3.049731,"median":-1.083984,"eighty":1.257668,"marketCap":189057771},{"date":"2023-01-13","current":-0.211826,"twenty":-3.049731,"median":-1.083984,"eighty":1.232001,"marketCap":190153758},{"date":"2023-01-20","current":-0.20267,"twenty":-3.049731,"median":-1.083984,"eighty":1.21001,"marketCap":181933855},{"date":"2023-01-27","current":-0.219152,"twenty":-3.049731,"median":-1.083984,"eighty":1.203988,"marketCap":196729680},{"date":"2023-02-03","current":-0.229529,"twenty":-3.049731,"median":-1.083984,"eighty":1.196963,"marketCap":206045571},{"date":"2023-02-10","current":-0.223425,"twenty":-3.049731,"median":-1.083984,"eighty":1.172347,"marketCap":200565635},{"date":"2023-02-17","current":-0.238686,"twenty":-3.049731,"median":-1.083984,"eighty":1.156052,"marketCap":214265474},{"date":"2023-02-24","current":-0.238076,"twenty":-3.049731,"median":-1.083984,"eighty":1.149868,"marketCap":213717480},{"date":"2023-03-03","current":-0.218541,"twenty":-3.049731,"median":-1.083984,"eighty":1.13789,"marketCap":196181687},{"date":"2023-03-10","current":-0.200228,"twenty":-3.049731,"median":-1.083984,"eighty":1.122412,"marketCap":179741881},{"date":"2023-03-17","current":-0.163601,"twenty":-3.049731,"median":-1.083984,"eighty":1.100877,"marketCap":146862268},{"date":"2023-03-24","current":-0.128195,"twenty":-3.049731,"median":-1.083984,"eighty":1.069446,"marketCap":115078643},{"date":"2023-03-31","current":-0.136741,"twenty":-3.048412,"median":-1.082216,"eighty":1.016876,"marketCap":122750552},{"date":"2023-04-06","current":-0.131247,"twenty":-3.049731,"median":-1.083984,"eighty":0.96937,"marketCap":117818611},{"date":"2023-04-14","current":-0.154444,"twenty":-3.051051,"median":-1.084055,"eighty":-0.131247,"marketCap":138642365},{"date":"2023-04-21","current":-0.156374,"twenty":-3.05237,"median":-1.084125,"eighty":-0.135764,"marketCap":117270617},{"date":"2023-04-28","current":-0.157836,"twenty":-3.05237,"median":-1.084125,"eighty":-0.145654,"marketCap":118366604},{"date":"2023-05-04","current":-0.145084,"twenty":-3.05237,"median":-1.084125,"eighty":-0.150827,"marketCap":108803704},{"date":"2023-05-12","current":-0.139222,"twenty":-3.05369,"median":-1.084643,"eighty":-0.153451,"marketCap":104407595},{"date":"2023-05-19","current":-0.150946,"twenty":-3.05369,"median":-1.084643,"eighty":-0.153451,"marketCap":113199813},{"date":"2023-05-26","current":-0.128964,"twenty":-3.05369,"median":-1.084643,"eighty":-0.153451,"marketCap":96714404},{"date":"2023-06-01","current":-0.131162,"twenty":-3.05369,"median":-1.084643,"eighty":-0.153451,"marketCap":98362945},{"date":"2023-06-09","current":-0.137757,"twenty":-3.065927,"median":-1.085751,"eighty":-0.15386,"marketCap":103308568},{"date":"2023-06-16","current":-0.134093,"twenty":-3.065927,"median":-1.085751,"eighty":-0.15386,"marketCap":100560999},{"date":"2023-06-23","current":-0.145084,"twenty":-3.072045,"median":-1.08634,"eighty":-0.154104,"marketCap":108803704},{"date":"2023-06-30","current":-0.089287,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":84506629},{"date":"2023-07-07","current":-0.090454,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":85611291},{"date":"2023-07-14","current":-0.097374,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":92161174},{"date":"2023-07-21","current":-0.092127,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":87194404},{"date":"2023-07-28","current":-0.092127,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":87194404},{"date":"2023-08-04","current":-0.149851,"twenty":-3.078164,"median":-1.091053,"eighty":-0.154566,"marketCap":141828873},{"date":"2023-08-11","current":-0.123613,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":116995023},{"date":"2023-08-18","current":-0.107287,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":101542850},{"date":"2023-08-25","current":-0.083963,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":79468318},{"date":"2023-09-01","current":-0.044897,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":42493475},{"date":"2023-09-08","current":-0.040285,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":38128236},{"date":"2023-09-15","current":-0.040273,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":38117199},{"date":"2023-09-22","current":-0.03681,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":34839131},{"date":"2023-09-29","current":-0.02695,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":25507122},{"date":"2023-10-06","current":-0.031498,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":29811656},{"date":"2023-10-13","current":-0.045439,"twenty":-3.078164,"median":-1.091053,"eighty":-0.155785,"marketCap":43006708}],"updateTime":1774724953702},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584095850","title":"Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584095850","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584095850?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472600,"startTime":"0","endTime":"0","summary":"RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by the dual emission of beta particles and Auger electrons  SYDNEY, Nov.  1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/18/3190037/0/en/Radiopharm-Theranostics-Receives-Approval-to-Initiate-Phase-1-Therapeutic-Trial-of-RAD-402-KLK3-mAb-with-Tb161-in-Advanced-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4533","RAD","BK4084","BK4128","PSA","BK4139","BK4585","BK4217","BK4588"],"gpt_icon":0},{"id":"2584267700","title":"Radiopharm Theranostics Gains Approval for Phase 1 Trial of RAD 402 in Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584267700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584267700?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:37","pubTimestamp":1763419044,"startTime":"0","endTime":"0","summary":"An update from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. Radiopharm Theranostics Limited has received approval from the Bellb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-gains-approval-for-phase-1-trial-of-rad-402-in-prostate-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-gains-approval-for-phase-1-trial-of-rad-402-in-prostate-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAD","BK4128"],"gpt_icon":0},{"id":"2584251126","title":"Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2584251126","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584251126?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384400,"startTime":"0","endTime":"0","summary":"Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189074/0/en/Radiopharm-Theranostics-Announces-50-Enrollment-in-Phase-2b-Clinical-Trial-of-RAD101-Imaging-in-Brain-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD","BK4128","BK4139","RADX","SRS"],"gpt_icon":0},{"id":"2584744647","title":"Artificial Intelligence Technology Solutions Secures Major RAD Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2584744647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584744647?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:33","pubTimestamp":1763379229,"startTime":"0","endTime":"0","summary":"Artificial Intelligence Technology Solutions ( ($AITX) ) has shared an announcement. On November 17, 2025, Artificial Intelligence Technology Solut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artificial-intelligence-technology-solutions-secures-major-rad-order?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artificial-intelligence-technology-solutions-secures-major-rad-order?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4128","RAD"],"gpt_icon":0},{"id":"2582722313","title":"Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204","url":"https://stock-news.laohu8.com/highlight/detail?id=2582722313","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582722313?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:30","pubTimestamp":1762954200,"startTime":"0","endTime":"0","summary":"Data Safety Monitoring Committee approves advancing to a higher dose of90mCi The first two Cohorts’ patients show tumor uptake and a favourable safety profile SYDNEY, Nov.  12, 2025  (GLOBE NEWSWIRE) ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186280/0/en/Radiopharm-Theranostics-starts-enrollment-of-the-Third-Cohort-of-Phase-1-Dose-Escalation-Clinical-Trial-of-177Lu-RAD204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","RAD","RADX","BK4139"],"gpt_icon":0},{"id":"2580202927","title":"T RAD Co Raises FY Net View to Y6.40B","url":"https://stock-news.laohu8.com/highlight/detail?id=2580202927","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580202927?lang=en_us&edition=fundamental","pubTime":"2025-11-04 15:30","pubTimestamp":1762241400,"startTime":"0","endTime":"0","summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"T RAD Co Raises FY Net View to Y6.40B","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","RAD"],"gpt_icon":0},{"id":"2580292825","title":"Artificial Intelligence Technology Solutions Secures Major RAD Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2580292825","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580292825?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:31","pubTimestamp":1762169515,"startTime":"0","endTime":"0","summary":"An announcement from Artificial Intelligence Technology Solutions ( ($AITX) ) is now available. On November 3, 2025, Artificial Intelligence Techno...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artificial-intelligence-technology-solutions-secures-major-rad-contract?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artificial-intelligence-technology-solutions-secures-major-rad-contract?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAD","BK4128"],"gpt_icon":0},{"id":"2577391406","title":"C-RAD AB Announces Share Repurchase Program to Optimize Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2577391406","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577391406?lang=en_us&edition=fundamental","pubTime":"2025-10-23 00:03","pubTimestamp":1761149019,"startTime":"0","endTime":"0","summary":"C-Rad AB Class B ( ($SE:CRAD.B) ) has provided an update. C-RAD AB has announced a decision to repurchase up to 597,000 of its own class B shares, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-ab-announces-share-repurchase-program-to-optimize-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-ab-announces-share-repurchase-program-to-optimize-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","LU0048573645.USD","LU0261945553.USD","LU0175139822.USD","SG9999002679.SGD","BK4585","SG9999004360.SGD","BK4085","LU0516422366.SGD","RAD","CRADF","BK4590","SG9999001135.SGD","SG9999013486.USD","LU0979878070.USD","BK4581","BK4588","LU2177674079.SGD","LU0289960550.SGD","LU1861220207.SGD","LU0516423091.SGD","BK4598","LU1242518931.SGD","LU0264606111.USD","LU0823038988.USD","BK4082","LU2543165471.USD","LU1861217088.USD","IE0034224299.USD","LU0572939691.SGD","LU1048588211.SGD","LU0210637038.USD","LU0348788117.USD","SG9999013478.USD","LU0823039010.USD","BK4135","LU2008162690.USD","SG9999006266.SGD","BK4551","LU0499858602.USD","SGXZ58947870.SGD","IE00BD6J9T35.USD","LU0737861269.HKD","LU0345775950.USD","LU2065171311.SGD","AB","LU2238330802.EUR","SG9999002406.SGD","LU0029874061.USD"],"gpt_icon":0},{"id":"2577080351","title":"C-RAD AB Reports Strong Q3 2025 Earnings and Strategic Growth Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2577080351","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577080351?lang=en_us&edition=fundamental","pubTime":"2025-10-22 01:32","pubTimestamp":1761067949,"startTime":"0","endTime":"0","summary":"C-Rad AB Class B ( ($SE:CRAD.B) ) just unveiled an update. C-RAD AB reported a positive earnings trend for the third quarter of 2025, with a 12% in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-ab-reports-strong-q3-2025-earnings-and-strategic-growth-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-ab-reports-strong-q3-2025-earnings-and-strategic-growth-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAD","AB","CRADF"],"gpt_icon":0},{"id":"2577238870","title":"C-RAD Announces Leadership Transition with New Acting CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2577238870","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577238870?lang=en_us&edition=fundamental","pubTime":"2025-10-22 00:34","pubTimestamp":1761064450,"startTime":"0","endTime":"0","summary":"C-Rad AB Class B ( ($SE:CRAD.B) ) has issued an update. C-RAD has announced a leadership change with CEO Cecilia de Leeuw stepping down and CFO Lin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-announces-leadership-transition-with-new-acting-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-announces-leadership-transition-with-new-acting-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0516422366.SGD","LU0572940350.SGD","LU0589944569.HKD","LU0264606111.USD","SGXZ58947870.SGD","LU1839390173.USD","SG9999014492.USD","LU2045819591.USD","LU2177674079.SGD","LU2065169927.USD","LU2125910849.SGD","LU0441851309.USD","LU0345776255.USD","SG9999002406.SGD","LU1242518931.SGD","SG9999001135.SGD","LU0499858438.USD","BK4085","SG9999006266.SGD","LU0737861269.HKD","SG9999013478.USD","LU1861217088.USD","RAD","BK4585","SG9999013460.SGD","LU0175139822.USD","LU0210637038.USD","LU2360107671.USD","SG9999004360.SGD","SG9999013486.USD","LU0048573645.USD","LU0516422440.USD","LU0516422952.EUR","LU0289960550.SGD","LU0823039010.USD","BK4551","SG9999005177.SGD","BK4548","LU0499858602.USD","LU2125910500.SGD","IE00BD6J9T35.USD","IE0034224299.USD","LU2152927971.USD","BK4220","IE0031814969.USD","SG9999002414.USD","LU2065171402.SGD","LU0072462343.USD","SG9999002679.SGD"],"gpt_icon":0},{"id":"2577704798","title":"C-RAD Expedites Q3 2025 Interim Report Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2577704798","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577704798?lang=en_us&edition=fundamental","pubTime":"2025-10-22 00:33","pubTimestamp":1761064436,"startTime":"0","endTime":"0","summary":"An announcement from C-Rad AB Class B ( ($SE:CRAD.B) ) is now available. C-RAD has announced an advancement in the approval process for its interim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-expedites-q3-2025-interim-report-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-expedites-q3-2025-interim-report-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SG9999005177.SGD","LU2125910849.SGD","BK4085","BK4548","LU0589944569.HKD","LU0499858438.USD","LU2045819591.USD","LU0345776255.USD","LU0516422366.SGD","SG9999013486.USD","IE00BD6J9T35.USD","SG9999002406.SGD","LU0289960550.SGD","SG9999013478.USD","LU0823039010.USD","LU0737861269.HKD","LU2065169927.USD","LU0441851309.USD","RAD","LU1861217088.USD","SG9999006266.SGD","LU1839390173.USD","BK4220","LU0264606111.USD","IE0034224299.USD","LU0072462343.USD","LU2360107671.USD","SG9999002414.USD","SG9999014492.USD","LU0048573645.USD","BK4551","SG9999002679.SGD","SGXZ58947870.SGD","IE0031814969.USD","LU0516422952.EUR","LU0210637038.USD","LU0175139822.USD","LU0499858602.USD","LU1242518931.SGD","LU2125910500.SGD","LU2177674079.SGD","SG9999013460.SGD","LU2152927971.USD","LU0572940350.SGD","SG9999004360.SGD","LU0516422440.USD","LU2065171402.SGD","SG9999001135.SGD"],"gpt_icon":0},{"id":"2577864025","title":"Press Release: Hilco Global Seeks Offers to Acquire Consumer IP Assets of Rite Aid(R)","url":"https://stock-news.laohu8.com/highlight/detail?id=2577864025","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577864025?lang=en_us&edition=fundamental","pubTime":"2025-10-21 01:36","pubTimestamp":1760981760,"startTime":"0","endTime":"0","summary":"Bids to acquire the assets are due by October 31, 2025. An auction, if necessary, will be held on November 6, 2025. The company reserves the right not to conduct an auction. Interested parties can click here to learn more or contact Hilco Global directly at Project+Road@hilcoglobal.com.David Peress, Hilco Global's Executive Director IP Services stated, \"This is a rare opportunity to acquire one of the most well-known retail healthcare brands in the U.S.\" Peress continued, \"The Rite Aid  brand can be immediately leveraged across multiple sectors--from ePharmacy and digital health, to health and beauty and consumer-packaged goods--to meaningfully engage with consumers across sales channels.\". About Hilco Global: Hilco Global, a subsidiary of ORIX Corporation USA, is a diversified financial services company that delivers integrated professional services and capital solutions that help clients maximize value and drive performance across the retail, commercial industrial, real estate, manuf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4585","BK4588","LU1481600234.SGD","IP","LU1169589451.USD","LU2463526074.USD","IE00B3T34201.USD","R","RAD","LU1481599808.USD","BK4136","BK4022","LU1487256676.USD","LU1169590202.USD","BK4128"],"gpt_icon":0},{"id":"2576072851","title":"Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2576072851","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576072851?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169315/0/en/Radiopharm-Theranostics-Provides-Positive-Clinical-Updates-Across-Four-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4183","SOC","RADX","DSMC","IE0009354923.USD","RAD","ODD","BK4139","BK4128"],"gpt_icon":0},{"id":"2575780784","title":"CVS Pharmacy completes acquisition of Rite Aid assets nationwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2575780784","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575780784?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:16","pubTimestamp":1760530560,"startTime":"0","endTime":"0","summary":"CVS Pharmacy announced the completion of its acquisition of select Rite Aid (RAD) assets nationwide. In total, the company acquired and is now oper...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvs-pharmacy-completes-acquisition-of-rite-aid-assets-nationwide-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvs-pharmacy-completes-acquisition-of-rite-aid-assets-nationwide-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU0070302665.USD","BK4128","LU1571399168.USD","LU0208291251.USD","IE00BZ1G4Q59.USD","BK4196","BK4585","LU0320765489.SGD","LU0006061336.USD","IE0002270589.USD","RAD","BK4581","LU1059921491.USD","CVS","LU0061475181.USD","BK4504","LU1983299246.USD","LU0162691827.USD","BK4588","LU0072461881.USD","LU1699723380.USD","IE00B19Z3B42.SGD","BK4550","IE00BSNM7G36.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2574813861","title":"C-RAD to Present Q3 2025 Interim Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2574813861","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574813861?lang=en_us&edition=fundamental","pubTime":"2025-10-09 14:29","pubTimestamp":1759991399,"startTime":"0","endTime":"0","summary":"C-Rad AB Class B ( ($SE:CRAD.B) ) has issued an announcement. C-RAD AB announced it will release its interim report for the third quarter of 2025 o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-to-present-q3-2025-interim-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-to-present-q3-2025-interim-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ58947870.SGD","LU0499858438.USD","IE0034224299.USD","LU0251143029.SGD","LU1839390173.USD","LU0572939691.SGD","BK4503","BK4585","LU0516422952.EUR","SG9999002406.SGD","SG9999013486.USD","SG9999002604.SGD","LU2238330802.EUR","LU2008162690.USD","SG9999002620.SGD","LU0210637038.USD","LU1242518931.SGD","SG9999013478.USD","BK4085","LU0345775950.USD","LU0516422366.SGD","LU0516423091.SGD","LU1770036033.HKD","SG9999001135.SGD","LU0441851309.USD","SG9999006266.SGD","BK4128","LU0264606111.USD","LU0345776255.USD","LU0572940350.SGD","LU0737861269.HKD","BK4554","LU1242518857.USD","LU2125910500.SGD","SG9999014484.SGD","LU0823039010.USD","RAD","SG9999002414.USD","LU2125910849.SGD","BK4535","LU2065170008.USD","BK4566","LU0048573645.USD","LU0979878070.USD","LU2543165471.USD","LU2177674079.SGD","BK4548","LU0072462343.USD","IE00BD6J9T35.USD"],"gpt_icon":0},{"id":"2572536060","title":"Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572536060","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572536060?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:00","pubTimestamp":1759320000,"startTime":"0","endTime":"0","summary":"Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead of the protocol-planned dose of 40mCiSYDNEY, Oct.  01, 2025  (GLOBE NEWSWIRE) -- Radioph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3159443/0/en/Radiopharm-Theranostics-Receives-Positive-Recommendation-from-Data-Safety-and-Monitoring-Committee-DSMC-to-Accelerate-177Lu-RAD202-Phase-1-HEAT-Dose-Escalation-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","HEAT","DSMC","RAD","AAQC","BK4139","BK4128"],"gpt_icon":0},{"id":"2571319010","title":"C-RAD Expands Czech Market Presence with Key Hospital Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2571319010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571319010?lang=en_us&edition=fundamental","pubTime":"2025-09-30 15:32","pubTimestamp":1759217558,"startTime":"0","endTime":"0","summary":"C-Rad AB Class B ( ($SE:CRAD.B) ) has provided an update. C-RAD has secured a significant order from Krajská Nemocnice Hospital in Liberec, Czech R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c-rad-expands-czech-market-presence-with-key-hospital-order?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c-rad-expands-czech-market-presence-with-key-hospital-order?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAD","LU2125910500.SGD","BK4220","LU0516422366.SGD","LU1839390173.USD","LU0048573645.USD","LU0499858602.USD","LU0345776255.USD","LU1861217088.USD","BK4503","BK4548","IE0034224299.USD","BK4588","BK4535","LU0823038988.USD","LU0441851309.USD","LU0516422952.EUR","LU0499858438.USD","BK4551","LU0345775950.USD","LU2008162690.USD","BK4554","LU2065171311.SGD","LU2065171402.SGD","LU0737861269.HKD","BK4585","LU0516422440.USD","LU0823039010.USD","LU0589944569.HKD","LU2543165471.USD","LU0516423091.SGD","LU2360107671.USD","SG9999001135.SGD","LU0572939691.SGD","LU1861220207.SGD","LU0572940350.SGD","LU1242518931.SGD","LU1242518857.USD","SG9999002414.USD","LU2177674079.SGD","SG9999002604.SGD","LU0516423174.USD","LU2065169927.USD","SG9999013478.USD","SG9999005177.SGD","SG9999014492.USD","LU0348788117.USD","SGXZ58947870.SGD","LU2045819591.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}